Heartflow, Inc. SEC filings HTFL

Heartflow, Inc. has 194 filings in SEC EDGAR's recent list, going back to Jul 10, 2009. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.

Heartflow, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Shareholder vote results
Jun 18, 2026 Jun 16, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 29, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Jun 16, 2026
S-8 Employee stock plan registration Mar 18, 2026 —
10-K Annual report Mar 18, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 18, 2026 Mar 18, 2026
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
10-Q Quarterly report Sep 19, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Sep 10, 2025 Sep 10, 2025
8-K Current report
Agreement ended
Aug 25, 2025 Aug 22, 2025
S-8 Employee stock plan registration Aug 11, 2025 —
S-8 Employee stock plan registration Aug 11, 2025 —
8-K Current report
Bylaw or fiscal year change, Other events
Aug 11, 2025 Aug 11, 2025
424B4 Prospectus Aug 8, 2025 —
EFFECT Filing Aug 7, 2025 —
CERT Filing Aug 7, 2025 —
8-A12B Filing Aug 7, 2025 —
CORRESP Letter to the SEC Aug 6, 2025 —
S-1/A Amended registration statement Aug 6, 2025 —
CORRESP Letter to the SEC Aug 5, 2025 —
CORRESP Letter to the SEC Aug 5, 2025 —
UPLOAD Letter from the SEC Aug 5, 2025 —
S-1/A Amended registration statement Aug 1, 2025 —
S-1 Registration statement Jul 17, 2025 —
DRS/A Filing Jun 23, 2025 —
DRSLTR Filing Jun 20, 2025 —
UPLOAD Letter from the SEC Apr 28, 2025 —
DRS/A Filing Apr 18, 2025 —
DRSLTR Filing Apr 18, 2025 —
UPLOAD Letter from the SEC Apr 10, 2025 —
DRS/A Filing Mar 27, 2025 —
DRSLTR Filing Mar 26, 2025 —
UPLOAD Letter from the SEC Mar 5, 2025 —
DRS Filing Feb 6, 2025 —
D Filing Jun 14, 2019 —
D Filing Dec 4, 2017 —
D/A Filing May 20, 2016 —
D Filing Feb 12, 2015 —
D/A Filing Feb 27, 2014 —
D/A Filing Feb 2, 2012 —
D Filing Dec 30, 2011 —
D/A Filing Feb 4, 2011 —
D Filing Sep 1, 2010 —
D Filing Jun 14, 2010 —
D Filing Apr 19, 2010 —
D Filing Jul 10, 2009 —

Showing 53 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
HTFL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Francisco, CA
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1464521
Former names
Cardiovascular Simulation, Inc. (until Jun 14, 2010)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.